nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Propranolol—migraine	0.0822	0.247	CbGbCtD
Conivaptan—CYP3A4—Amitriptyline—migraine	0.0711	0.214	CbGbCtD
Conivaptan—CYP3A4—Valproic Acid—migraine	0.0648	0.195	CbGbCtD
Conivaptan—CYP3A4—Topiramate—migraine	0.0585	0.176	CbGbCtD
Conivaptan—CYP3A4—Verapamil—migraine	0.0564	0.169	CbGbCtD
Conivaptan—AVPR2—G alpha (s) signalling events—CALCRL—migraine	0.0095	0.0314	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—RAMP1—migraine	0.0095	0.0314	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide GPCRs—EDNRA—migraine	0.00576	0.019	CbGpPWpGaD
Conivaptan—AVPR2—Peptide GPCRs—EDNRA—migraine	0.00571	0.0189	CbGpPWpGaD
Conivaptan—Pharyngolaryngeal pain—Timolol—migraine	0.00526	0.0144	CcSEcCtD
Conivaptan—Laryngeal pain—Timolol—migraine	0.00521	0.0143	CcSEcCtD
Conivaptan—Oral candidiasis—Gabapentin—migraine	0.00521	0.0143	CcSEcCtD
Conivaptan—Orthostatic hypotension—Amitriptyline—migraine	0.00498	0.0137	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—HTR2B—migraine	0.00465	0.0154	CbGpPWpGaD
Conivaptan—Hypoglycaemia—Propranolol—migraine	0.00455	0.0125	CcSEcCtD
Conivaptan—Pollakiuria—Amitriptyline—migraine	0.00436	0.0119	CcSEcCtD
Conivaptan—Cardiac failure—Verapamil—migraine	0.00419	0.0115	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00416	0.0138	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—NPS—migraine	0.00396	0.0131	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00387	0.0128	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00384	0.0127	CbGpPWpGaD
Conivaptan—Orthostatic hypotension—Verapamil—migraine	0.00373	0.0102	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—TRPM8—migraine	0.00369	0.0122	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—CALCA—migraine	0.00364	0.012	CbGpPWpGaD
Conivaptan—Urine output increased—Valproic Acid—migraine	0.00361	0.0099	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.0036	0.0119	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00357	0.0118	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CALCRL—migraine	0.00347	0.0115	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—RAMP1—migraine	0.00347	0.0115	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—RAMP1—migraine	0.00345	0.0114	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CALCRL—migraine	0.00345	0.0114	CbGpPWpGaD
Conivaptan—Infestation NOS—Propranolol—migraine	0.00342	0.00939	CcSEcCtD
Conivaptan—Infestation—Propranolol—migraine	0.00342	0.00939	CcSEcCtD
Conivaptan—AVPR2—G alpha (s) signalling events—HTR7—migraine	0.0034	0.0113	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00331	0.011	CbGpPWpGaD
Conivaptan—Polyuria—Valproic Acid—migraine	0.0033	0.00905	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00329	0.0109	CbGpPWpGaD
Conivaptan—Pollakiuria—Verapamil—migraine	0.00326	0.00895	CcSEcCtD
Conivaptan—Candida infection—Gabapentin—migraine	0.00316	0.00867	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00308	0.0102	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00306	0.0101	CbGpPWpGaD
Conivaptan—Urine output increased—Gabapentin—migraine	0.00299	0.00821	CcSEcCtD
Conivaptan—Hyponatraemia—Valproic Acid—migraine	0.00291	0.00798	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—TAC1—migraine	0.00287	0.0095	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—NPS—migraine	0.00287	0.0095	CbGpPWpGaD
Conivaptan—Sepsis—Gabapentin—migraine	0.00287	0.00788	CcSEcCtD
Conivaptan—Cardiac disorder—Propranolol—migraine	0.00285	0.00782	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—NPS—migraine	0.00284	0.00938	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—TAC1—migraine	0.00284	0.00938	CbGpPWpGaD
Conivaptan—Hypertension—Amitriptyline—migraine	0.00284	0.00778	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—HTR2C—migraine	0.00282	0.00932	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—NPS—migraine	0.00282	0.00932	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—TAC1—migraine	0.00282	0.00932	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ATP1A2—migraine	0.0028	0.00925	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—ATP1A3—migraine	0.0028	0.00925	CbGpPWpGaD
Conivaptan—Phlebitis—Gabapentin—migraine	0.00279	0.00765	CcSEcCtD
Conivaptan—Oedema peripheral—Verapamil—migraine	0.00279	0.00764	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—EDNRA—migraine	0.00274	0.00907	CbGpPWpGaD
Conivaptan—Dry mouth—Amitriptyline—migraine	0.00274	0.0075	CcSEcCtD
Conivaptan—Polyuria—Gabapentin—migraine	0.00274	0.0075	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—EDNRA—migraine	0.00271	0.00895	CbGpPWpGaD
Conivaptan—Confusional state—Amitriptyline—migraine	0.0027	0.00742	CcSEcCtD
Conivaptan—Mental disorder—Propranolol—migraine	0.00269	0.00739	CcSEcCtD
Conivaptan—AVPR2—Peptide ligand-binding receptors—EDNRA—migraine	0.00269	0.00889	CbGpPWpGaD
Conivaptan—Erythema—Propranolol—migraine	0.00268	0.00734	CcSEcCtD
Conivaptan—Candida infection—Topiramate—migraine	0.00266	0.00729	CcSEcCtD
Conivaptan—Orthostatic hypotension—Valproic Acid—migraine	0.00265	0.00726	CcSEcCtD
Conivaptan—Hypoglycaemia—Timolol—migraine	0.00264	0.00725	CcSEcCtD
Conivaptan—Cardiac failure—Timolol—migraine	0.00264	0.00725	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00257	0.0085	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00257	0.0085	CbGpPWpGaD
Conivaptan—Atrial fibrillation—Gabapentin—migraine	0.00254	0.00695	CcSEcCtD
Conivaptan—Thirst—Gabapentin—migraine	0.00252	0.00692	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—HTR1D—migraine	0.00252	0.00835	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00252	0.00834	CbGpPWpGaD
Conivaptan—Urine output increased—Topiramate—migraine	0.00252	0.0069	CcSEcCtD
Conivaptan—Hypotension—Amitriptyline—migraine	0.00251	0.00687	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—HTR1D—migraine	0.00251	0.00829	CbGpPWpGaD
Conivaptan—Cardiac failure—Gabapentin—migraine	0.00246	0.00675	CcSEcCtD
Conivaptan—Hypoglycaemia—Gabapentin—migraine	0.00246	0.00675	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00245	0.00811	CbGpPWpGaD
Conivaptan—Insomnia—Amitriptyline—migraine	0.00243	0.00665	CcSEcCtD
Conivaptan—Hyponatraemia—Gabapentin—migraine	0.00241	0.00661	CcSEcCtD
Conivaptan—AVPR2—Transmembrane transport of small molecules—HTR3A—migraine	0.00238	0.00787	CbGpPWpGaD
Conivaptan—Phlebitis—Topiramate—migraine	0.00235	0.00643	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—HTR2B—migraine	0.00235	0.00776	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00234	0.00775	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR2B—migraine	0.00233	0.0077	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00233	0.00769	CbGpPWpGaD
Conivaptan—Pollakiuria—Valproic Acid—migraine	0.00231	0.00635	CcSEcCtD
Conivaptan—Polyuria—Topiramate—migraine	0.0023	0.00631	CcSEcCtD
Conivaptan—Constipation—Amitriptyline—migraine	0.00229	0.00629	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00226	0.0062	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00226	0.00746	CbGpPWpGaD
Conivaptan—Pneumonia—Valproic Acid—migraine	0.00225	0.00616	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00224	0.00741	CbGpPWpGaD
Conivaptan—Dehydration—Gabapentin—migraine	0.00223	0.00613	CcSEcCtD
Conivaptan—Feeling abnormal—Amitriptyline—migraine	0.00221	0.00606	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00218	0.00721	CbGpPWpGaD
Conivaptan—Urinary tract infection—Valproic Acid—migraine	0.00217	0.00595	CcSEcCtD
Conivaptan—Infection—Propranolol—migraine	0.00217	0.00595	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00216	0.00715	CbGpPWpGaD
Conivaptan—Nervous system disorder—Propranolol—migraine	0.00214	0.00587	CcSEcCtD
Conivaptan—Hypertension—Verapamil—migraine	0.00213	0.00583	CcSEcCtD
Conivaptan—Thirst—Topiramate—migraine	0.00212	0.00582	CcSEcCtD
Conivaptan—Skin disorder—Propranolol—migraine	0.00212	0.00582	CcSEcCtD
Conivaptan—Body temperature increased—Amitriptyline—migraine	0.00212	0.00581	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00212	0.00701	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.0021	0.00696	CbGpPWpGaD
Conivaptan—Hypoglycaemia—Topiramate—migraine	0.00207	0.00568	CcSEcCtD
Conivaptan—Dry mouth—Verapamil—migraine	0.00205	0.00562	CcSEcCtD
Conivaptan—Hyponatraemia—Topiramate—migraine	0.00203	0.00557	CcSEcCtD
Conivaptan—Confusional state—Verapamil—migraine	0.00203	0.00555	CcSEcCtD
Conivaptan—Hyperglycaemia—Timolol—migraine	0.00201	0.00552	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00201	0.00664	CbGpPWpGaD
Conivaptan—Infection—Verapamil—migraine	0.002	0.00547	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00199	0.00659	CbGpPWpGaD
Conivaptan—Urinary tract disorder—Valproic Acid—migraine	0.00198	0.00543	CcSEcCtD
Conivaptan—Insomnia—Propranolol—migraine	0.00198	0.00542	CcSEcCtD
Conivaptan—Oedema peripheral—Valproic Acid—migraine	0.00197	0.00542	CcSEcCtD
Conivaptan—Urethral disorder—Valproic Acid—migraine	0.00197	0.00539	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—RAMP1—migraine	0.00196	0.00649	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CALCRL—migraine	0.00196	0.00649	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CALCRL—migraine	0.00195	0.00644	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—RAMP1—migraine	0.00195	0.00644	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00193	0.00639	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00192	0.00635	CbGpPWpGaD
Conivaptan—Pollakiuria—Gabapentin—migraine	0.00192	0.00526	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00191	0.00631	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.0019	0.00629	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.0019	0.00629	CbGpPWpGaD
Conivaptan—Pruritus—Amitriptyline—migraine	0.0019	0.0052	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00189	0.00627	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00189	0.00625	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00189	0.00625	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Propranolol—migraine	0.00189	0.00517	CcSEcCtD
Conivaptan—Dehydration—Topiramate—migraine	0.00188	0.00515	CcSEcCtD
Conivaptan—Hypotension—Verapamil—migraine	0.00188	0.00515	CcSEcCtD
Conivaptan—Hyperglycaemia—Gabapentin—migraine	0.00187	0.00514	CcSEcCtD
Conivaptan—Constipation—Propranolol—migraine	0.00187	0.00512	CcSEcCtD
Conivaptan—Pain—Propranolol—migraine	0.00187	0.00512	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00187	0.00617	CbGpPWpGaD
Conivaptan—Pneumonia—Gabapentin—migraine	0.00186	0.00511	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00185	0.00613	CbGpPWpGaD
Conivaptan—Infestation NOS—Gabapentin—migraine	0.00185	0.00508	CcSEcCtD
Conivaptan—Infestation—Gabapentin—migraine	0.00185	0.00508	CcSEcCtD
Conivaptan—Orthostatic hypotension—Topiramate—migraine	0.00185	0.00506	CcSEcCtD
Conivaptan—Hypokalaemia—Topiramate—migraine	0.00184	0.00504	CcSEcCtD
Conivaptan—Diarrhoea—Amitriptyline—migraine	0.00184	0.00503	CcSEcCtD
Conivaptan—Angiopathy—Valproic Acid—migraine	0.00182	0.00499	CcSEcCtD
Conivaptan—Insomnia—Verapamil—migraine	0.00182	0.00498	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00182	0.006	CbGpPWpGaD
Conivaptan—Mediastinal disorder—Valproic Acid—migraine	0.00181	0.00496	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.0018	0.00596	CbGpPWpGaD
Conivaptan—Urinary tract infection—Gabapentin—migraine	0.0018	0.00494	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—RAMP1—migraine	0.00178	0.00589	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CALCRL—migraine	0.00178	0.00589	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CALCRL—migraine	0.00177	0.00585	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—RAMP1—migraine	0.00177	0.00585	CbGpPWpGaD
Conivaptan—Haematuria—Gabapentin—migraine	0.00177	0.00484	CcSEcCtD
Conivaptan—Oedema peripheral—Timolol—migraine	0.00176	0.00482	CcSEcCtD
Conivaptan—Mental disorder—Valproic Acid—migraine	0.00176	0.00482	CcSEcCtD
Conivaptan—Malnutrition—Valproic Acid—migraine	0.00175	0.00479	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—HTR2A—migraine	0.00173	0.00572	CbGpPWpGaD
Conivaptan—Body temperature increased—Propranolol—migraine	0.00173	0.00473	CcSEcCtD
Conivaptan—Constipation—Verapamil—migraine	0.00172	0.00471	CcSEcCtD
Conivaptan—Pain—Verapamil—migraine	0.00172	0.00471	CcSEcCtD
Conivaptan—Vomiting—Amitriptyline—migraine	0.00171	0.00468	CcSEcCtD
Conivaptan—Headache—Amitriptyline—migraine	0.00168	0.00461	CcSEcCtD
Conivaptan—Cardiac disorder—Timolol—migraine	0.00166	0.00454	CcSEcCtD
Conivaptan—Feeling abnormal—Verapamil—migraine	0.00166	0.00454	CcSEcCtD
Conivaptan—Urinary tract disorder—Gabapentin—migraine	0.00164	0.0045	CcSEcCtD
Conivaptan—Oedema peripheral—Gabapentin—migraine	0.00164	0.00449	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00163	0.00541	CbGpPWpGaD
Conivaptan—Urethral disorder—Gabapentin—migraine	0.00163	0.00447	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00162	0.00537	CbGpPWpGaD
Conivaptan—Angiopathy—Timolol—migraine	0.00162	0.00444	CcSEcCtD
Conivaptan—Pollakiuria—Topiramate—migraine	0.00161	0.00443	CcSEcCtD
Conivaptan—Anaemia—Valproic Acid—migraine	0.00161	0.00442	CcSEcCtD
Conivaptan—Mediastinal disorder—Timolol—migraine	0.00161	0.00441	CcSEcCtD
Conivaptan—Nausea—Amitriptyline—migraine	0.00159	0.00437	CcSEcCtD
Conivaptan—Hyperglycaemia—Topiramate—migraine	0.00158	0.00432	CcSEcCtD
Conivaptan—Pneumonia—Topiramate—migraine	0.00157	0.0043	CcSEcCtD
Conivaptan—Mental disorder—Timolol—migraine	0.00156	0.00429	CcSEcCtD
Conivaptan—Infestation—Topiramate—migraine	0.00156	0.00427	CcSEcCtD
Conivaptan—Infestation NOS—Topiramate—migraine	0.00156	0.00427	CcSEcCtD
Conivaptan—Malnutrition—Timolol—migraine	0.00155	0.00426	CcSEcCtD
Conivaptan—Erythema—Timolol—migraine	0.00155	0.00426	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.00155	0.00511	CbGpPWpGaD
Conivaptan—Cardiac disorder—Gabapentin—migraine	0.00154	0.00423	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—HTR1B—migraine	0.00153	0.00506	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR1B—migraine	0.00152	0.00502	CbGpPWpGaD
Conivaptan—Urinary tract infection—Topiramate—migraine	0.00151	0.00415	CcSEcCtD
Conivaptan—Hypertension—Valproic Acid—migraine	0.00151	0.00413	CcSEcCtD
Conivaptan—Mediastinal disorder—Gabapentin—migraine	0.0015	0.00411	CcSEcCtD
Conivaptan—Diarrhoea—Propranolol—migraine	0.00149	0.0041	CcSEcCtD
Conivaptan—Haematuria—Topiramate—migraine	0.00149	0.00407	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00148	0.00405	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—HTR1A—migraine	0.00147	0.00487	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR1A—migraine	0.00146	0.00483	CbGpPWpGaD
Conivaptan—Mental disorder—Gabapentin—migraine	0.00146	0.00399	CcSEcCtD
Conivaptan—Dry mouth—Valproic Acid—migraine	0.00145	0.00399	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—NPS—migraine	0.00145	0.00479	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—TAC1—migraine	0.00145	0.00479	CbGpPWpGaD
Conivaptan—Malnutrition—Gabapentin—migraine	0.00145	0.00397	CcSEcCtD
Conivaptan—Erythema—Gabapentin—migraine	0.00145	0.00397	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—NPS—migraine	0.00144	0.00476	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—TAC1—migraine	0.00144	0.00476	CbGpPWpGaD
Conivaptan—Confusional state—Valproic Acid—migraine	0.00144	0.00394	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR1D—migraine	0.00143	0.00472	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HTR2C—migraine	0.00142	0.0047	CbGpPWpGaD
Conivaptan—Pruritus—Verapamil—migraine	0.00142	0.0039	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—HTR1D—migraine	0.00142	0.00468	CbGpPWpGaD
Conivaptan—Infection—Valproic Acid—migraine	0.00142	0.00388	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—HTR2C—migraine	0.00141	0.00467	CbGpPWpGaD
Conivaptan—Nervous system disorder—Valproic Acid—migraine	0.0014	0.00383	CcSEcCtD
Conivaptan—Vomiting—Propranolol—migraine	0.00139	0.00381	CcSEcCtD
Conivaptan—Skin disorder—Valproic Acid—migraine	0.00138	0.00379	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—EDNRA—migraine	0.00138	0.00457	CbGpPWpGaD
Conivaptan—Urinary tract disorder—Topiramate—migraine	0.00138	0.00379	CcSEcCtD
Conivaptan—Oedema peripheral—Topiramate—migraine	0.00138	0.00378	CcSEcCtD
Conivaptan—Diarrhoea—Verapamil—migraine	0.00137	0.00377	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—EDNRA—migraine	0.00137	0.00454	CbGpPWpGaD
Conivaptan—Urethral disorder—Topiramate—migraine	0.00137	0.00376	CcSEcCtD
Conivaptan—Hypertension—Timolol—migraine	0.00134	0.00368	CcSEcCtD
Conivaptan—Anaemia—Gabapentin—migraine	0.00134	0.00367	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00134	0.00442	CbGpPWpGaD
Conivaptan—Hypotension—Valproic Acid—migraine	0.00133	0.00365	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CALCA—migraine	0.00133	0.0044	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00133	0.00439	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2B—migraine	0.00133	0.00438	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CALCA—migraine	0.00132	0.00437	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2B—migraine	0.00132	0.00435	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00131	0.0036	CcSEcCtD
Conivaptan—Cardiac disorder—Topiramate—migraine	0.0013	0.00356	CcSEcCtD
Conivaptan—Nausea—Propranolol—migraine	0.0013	0.00356	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—HTR1D—migraine	0.0013	0.00428	CbGpPWpGaD
Conivaptan—Dry mouth—Timolol—migraine	0.00129	0.00355	CcSEcCtD
Conivaptan—Insomnia—Valproic Acid—migraine	0.00129	0.00353	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—HTR1D—migraine	0.00129	0.00425	CbGpPWpGaD
Conivaptan—Confusional state—Timolol—migraine	0.00128	0.00351	CcSEcCtD
Conivaptan—Vomiting—Verapamil—migraine	0.00128	0.0035	CcSEcCtD
Conivaptan—Angiopathy—Topiramate—migraine	0.00127	0.00348	CcSEcCtD
Conivaptan—Mediastinal disorder—Topiramate—migraine	0.00126	0.00346	CcSEcCtD
Conivaptan—Infection—Timolol—migraine	0.00126	0.00345	CcSEcCtD
Conivaptan—Headache—Verapamil—migraine	0.00126	0.00345	CcSEcCtD
Conivaptan—Hypertension—Gabapentin—migraine	0.00125	0.00343	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—HTR7—migraine	0.00124	0.00412	CbGpPWpGaD
Conivaptan—Nervous system disorder—Timolol—migraine	0.00124	0.00341	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—HTR7—migraine	0.00124	0.00409	CbGpPWpGaD
Conivaptan—Skin disorder—Timolol—migraine	0.00123	0.00338	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Valproic Acid—migraine	0.00123	0.00337	CcSEcCtD
Conivaptan—Mental disorder—Topiramate—migraine	0.00123	0.00336	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00122	0.00335	CcSEcCtD
Conivaptan—Pain—Valproic Acid—migraine	0.00122	0.00334	CcSEcCtD
Conivaptan—Constipation—Valproic Acid—migraine	0.00122	0.00334	CcSEcCtD
Conivaptan—Erythema—Topiramate—migraine	0.00122	0.00334	CcSEcCtD
Conivaptan—Malnutrition—Topiramate—migraine	0.00122	0.00334	CcSEcCtD
Conivaptan—Dry mouth—Gabapentin—migraine	0.0012	0.0033	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2B—migraine	0.0012	0.00398	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2B—migraine	0.0012	0.00395	CbGpPWpGaD
Conivaptan—Nausea—Verapamil—migraine	0.00119	0.00327	CcSEcCtD
Conivaptan—Confusional state—Gabapentin—migraine	0.00119	0.00327	CcSEcCtD
Conivaptan—Hypotension—Timolol—migraine	0.00118	0.00325	CcSEcCtD
Conivaptan—Feeling abnormal—Valproic Acid—migraine	0.00117	0.00322	CcSEcCtD
Conivaptan—Infection—Gabapentin—migraine	0.00117	0.00322	CcSEcCtD
Conivaptan—Nervous system disorder—Gabapentin—migraine	0.00116	0.00318	CcSEcCtD
Conivaptan—Skin disorder—Gabapentin—migraine	0.00115	0.00315	CcSEcCtD
Conivaptan—Insomnia—Timolol—migraine	0.00115	0.00315	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00114	0.00379	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00114	0.00376	CbGpPWpGaD
Conivaptan—Body temperature increased—Valproic Acid—migraine	0.00113	0.00309	CcSEcCtD
Conivaptan—Anaemia—Topiramate—migraine	0.00113	0.00309	CcSEcCtD
Conivaptan—Hypotension—Gabapentin—migraine	0.0011	0.00303	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Timolol—migraine	0.00109	0.003	CcSEcCtD
Conivaptan—Pain—Timolol—migraine	0.00108	0.00297	CcSEcCtD
Conivaptan—Insomnia—Gabapentin—migraine	0.00107	0.00293	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—RAMP1—migraine	0.00105	0.00348	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CALCRL—migraine	0.00105	0.00348	CbGpPWpGaD
Conivaptan—Hypertension—Topiramate—migraine	0.00105	0.00288	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—RAMP1—migraine	0.00105	0.00346	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CALCRL—migraine	0.00105	0.00346	CbGpPWpGaD
Conivaptan—Feeling abnormal—Timolol—migraine	0.00104	0.00287	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.00103	0.00282	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Gabapentin—migraine	0.00102	0.0028	CcSEcCtD
Conivaptan—Dry mouth—Topiramate—migraine	0.00101	0.00278	CcSEcCtD
Conivaptan—Pain—Gabapentin—migraine	0.00101	0.00277	CcSEcCtD
Conivaptan—Constipation—Gabapentin—migraine	0.00101	0.00277	CcSEcCtD
Conivaptan—Pruritus—Valproic Acid—migraine	0.00101	0.00276	CcSEcCtD
Conivaptan—Body temperature increased—Timolol—migraine	0.001	0.00275	CcSEcCtD
Conivaptan—Confusional state—Topiramate—migraine	0.001	0.00275	CcSEcCtD
Conivaptan—Infection—Topiramate—migraine	0.000987	0.00271	CcSEcCtD
Conivaptan—Diarrhoea—Valproic Acid—migraine	0.000975	0.00267	CcSEcCtD
Conivaptan—Nervous system disorder—Topiramate—migraine	0.000974	0.00267	CcSEcCtD
Conivaptan—Feeling abnormal—Gabapentin—migraine	0.000973	0.00267	CcSEcCtD
Conivaptan—Skin disorder—Topiramate—migraine	0.000965	0.00265	CcSEcCtD
Conivaptan—Body temperature increased—Gabapentin—migraine	0.000933	0.00256	CcSEcCtD
Conivaptan—Hypotension—Topiramate—migraine	0.000928	0.00255	CcSEcCtD
Conivaptan—Vomiting—Valproic Acid—migraine	0.000906	0.00248	CcSEcCtD
Conivaptan—Insomnia—Topiramate—migraine	0.000898	0.00246	CcSEcCtD
Conivaptan—Pruritus—Timolol—migraine	0.000897	0.00246	CcSEcCtD
Conivaptan—Headache—Valproic Acid—migraine	0.000892	0.00245	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—HTR2A—migraine	0.000872	0.00288	CbGpPWpGaD
Conivaptan—Diarrhoea—Timolol—migraine	0.000868	0.00238	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—HTR2A—migraine	0.000866	0.00286	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR1B—migraine	0.000864	0.00286	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR1B—migraine	0.000858	0.00284	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Topiramate—migraine	0.000858	0.00235	CcSEcCtD
Conivaptan—Constipation—Topiramate—migraine	0.00085	0.00233	CcSEcCtD
Conivaptan—Pain—Topiramate—migraine	0.00085	0.00233	CcSEcCtD
Conivaptan—Nausea—Valproic Acid—migraine	0.000846	0.00232	CcSEcCtD
Conivaptan—Pruritus—Gabapentin—migraine	0.000835	0.00229	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR1A—migraine	0.000832	0.00275	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR1A—migraine	0.000826	0.00273	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—NPS—migraine	0.000819	0.00271	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—TAC1—migraine	0.000819	0.00271	CbGpPWpGaD
Conivaptan—Feeling abnormal—Topiramate—migraine	0.000819	0.00224	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—NPS—migraine	0.000813	0.00269	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—TAC1—migraine	0.000813	0.00269	CbGpPWpGaD
Conivaptan—Diarrhoea—Gabapentin—migraine	0.000808	0.00222	CcSEcCtD
Conivaptan—Vomiting—Timolol—migraine	0.000806	0.00221	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2C—migraine	0.000803	0.00266	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2C—migraine	0.000797	0.00264	CbGpPWpGaD
Conivaptan—Headache—Timolol—migraine	0.000794	0.00218	CcSEcCtD
Conivaptan—Body temperature increased—Topiramate—migraine	0.000785	0.00215	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—HTR1B—migraine	0.000785	0.00259	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—EDNRA—migraine	0.000781	0.00258	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR1B—migraine	0.000779	0.00258	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—EDNRA—migraine	0.000776	0.00257	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR1D—migraine	0.000765	0.00253	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR1D—migraine	0.00076	0.00251	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR1A—migraine	0.000755	0.0025	CbGpPWpGaD
Conivaptan—Nausea—Timolol—migraine	0.000753	0.00207	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—CALCA—migraine	0.000752	0.00249	CbGpPWpGaD
Conivaptan—Vomiting—Gabapentin—migraine	0.000751	0.00206	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—HTR1A—migraine	0.00075	0.00248	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CALCA—migraine	0.000747	0.00247	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—TAC1—migraine	0.000744	0.00246	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—NPS—migraine	0.000744	0.00246	CbGpPWpGaD
Conivaptan—Headache—Gabapentin—migraine	0.00074	0.00203	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—TAC1—migraine	0.000738	0.00244	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NPS—migraine	0.000738	0.00244	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2C—migraine	0.000729	0.00241	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2C—migraine	0.000724	0.0024	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2B—migraine	0.000711	0.00235	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—EDNRA—migraine	0.00071	0.00235	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2B—migraine	0.000706	0.00234	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—EDNRA—migraine	0.000704	0.00233	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR7—migraine	0.000704	0.00233	CbGpPWpGaD
Conivaptan—Pruritus—Topiramate—migraine	0.000703	0.00193	CcSEcCtD
Conivaptan—Nausea—Gabapentin—migraine	0.000701	0.00192	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—HTR7—migraine	0.000698	0.00231	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CALCA—migraine	0.000683	0.00226	CbGpPWpGaD
Conivaptan—Diarrhoea—Topiramate—migraine	0.00068	0.00186	CcSEcCtD
Conivaptan—AVPR2—Signaling by GPCR—CALCA—migraine	0.000678	0.00224	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR7—migraine	0.000639	0.00211	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR7—migraine	0.000634	0.0021	CbGpPWpGaD
Conivaptan—Vomiting—Topiramate—migraine	0.000632	0.00173	CcSEcCtD
Conivaptan—AVPR1A—Signaling Pathways—LRP1—migraine	0.000626	0.00207	CbGpPWpGaD
Conivaptan—Headache—Topiramate—migraine	0.000622	0.00171	CcSEcCtD
Conivaptan—AVPR2—Signaling Pathways—LRP1—migraine	0.000622	0.00206	CbGpPWpGaD
Conivaptan—Nausea—Topiramate—migraine	0.00059	0.00162	CcSEcCtD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2A—migraine	0.000493	0.00163	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2A—migraine	0.000489	0.00162	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH4—migraine	0.00048	0.00159	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH4—migraine	0.000477	0.00158	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR1B—migraine	0.000463	0.00153	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR1B—migraine	0.00046	0.00152	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2A—migraine	0.000447	0.00148	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR1A—migraine	0.000446	0.00148	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2A—migraine	0.000444	0.00147	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR1A—migraine	0.000443	0.00146	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TAC1—migraine	0.000439	0.00145	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPS—migraine	0.000439	0.00145	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PGR—migraine	0.000439	0.00145	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TAC1—migraine	0.000436	0.00144	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PGR—migraine	0.000436	0.00144	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPS—migraine	0.000436	0.00144	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2C—migraine	0.000431	0.00143	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2C—migraine	0.000428	0.00141	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EDNRA—migraine	0.000419	0.00139	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EDNRA—migraine	0.000416	0.00138	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NOTCH3—migraine	0.000408	0.00135	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NOTCH3—migraine	0.000406	0.00134	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CALCA—migraine	0.000403	0.00133	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CALCA—migraine	0.000401	0.00132	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR7—migraine	0.000377	0.00125	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR7—migraine	0.000375	0.00124	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TGFBR2—migraine	0.000325	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TGFBR2—migraine	0.000323	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2A—migraine	0.000264	0.000874	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2A—migraine	0.000262	0.000868	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ESR1—migraine	0.000235	0.000776	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ESR1—migraine	0.000233	0.00077	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CACNA1A—migraine	0.000111	0.000368	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—migraine	3.68e-05	0.000122	CbGpPWpGaD
